These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 37947332)
1. Racial disparities in prostate cancer mortality: a model-based decomposition of contributing factors. Gulati R; Nyame YA; Lange JM; Shoag JE; Tsodikov A; Etzioni R J Natl Cancer Inst Monogr; 2023 Nov; 2023(62):212-218. PubMed ID: 37947332 [TBL] [Abstract][Full Text] [Related]
2. Trends in prostate cancer mortality among black men and white men in the United States. Chu KC; Tarone RE; Freeman HP Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516 [TBL] [Abstract][Full Text] [Related]
3. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease. Sarabu N; Dong W; Koroukian SM Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622 [TBL] [Abstract][Full Text] [Related]
4. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA. Lediju O; Ikuemonisan J; Salami SS; Adejoro O J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310 [TBL] [Abstract][Full Text] [Related]
5. Geographic Distribution of Racial Differences in Prostate Cancer Mortality. Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449 [TBL] [Abstract][Full Text] [Related]
6. Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men. Powell IJ; Vigneau FD; Bock CH; Ruterbusch J; Heilbrun LK Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1505-11. PubMed ID: 24802741 [TBL] [Abstract][Full Text] [Related]
7. Racial disparities in late-stage prostate cancer: a SEER analysis 2005-2015. Rodriguez S; Sparks AD; Zhou H; Amdu RL; Lin J Can J Urol; 2019 Oct; 26(5):9946-9951. PubMed ID: 31629445 [TBL] [Abstract][Full Text] [Related]
8. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race. Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048 [TBL] [Abstract][Full Text] [Related]
9. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States. Mahal BA; Chen YW; Muralidhar V; Mahal AR; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Yu JB; Feng FY; Kim SP; Beard CJ; Martin NE; Trinh QD; Nguyen PL Ann Oncol; 2017 May; 28(5):1098-1104. PubMed ID: 28453693 [TBL] [Abstract][Full Text] [Related]
10. The Relative Importance of Race Compared to Health Care and Social Factors in Predicting Prostate Cancer Mortality: A Random Forest Approach. Hanson HA; Martin C; O'Neil B; Leiser CL; Mayer EN; Smith KR; Lowrance WT J Urol; 2019 Dec; 202(6):1209-1216. PubMed ID: 31246547 [TBL] [Abstract][Full Text] [Related]
11. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation. Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321 [TBL] [Abstract][Full Text] [Related]
12. Is prostate cancer different in black men? Answers from 3 natural history models. Tsodikov A; Gulati R; de Carvalho TM; Heijnsdijk EAM; Hunter-Merrill RA; Mariotto AB; de Koning HJ; Etzioni R Cancer; 2017 Jun; 123(12):2312-2319. PubMed ID: 28436011 [TBL] [Abstract][Full Text] [Related]
13. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. Powell IJ; Bock CH; Ruterbusch JJ; Sakr W J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055 [TBL] [Abstract][Full Text] [Related]
14. Ultraviolet index and racial differences in prostate cancer incidence and mortality. Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754 [TBL] [Abstract][Full Text] [Related]
15. Racial disparities in prostate cancer survival in a screened population: Reality versus artifact. Kaur D; Ulloa-Pérez E; Gulati R; Etzioni R Cancer; 2018 Apr; 124(8):1752-1759. PubMed ID: 29370459 [TBL] [Abstract][Full Text] [Related]
16. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Lathan C; Kim SP; Trinh QD; Nguyen PL Urol Oncol; 2014 Nov; 32(8):1285-91. PubMed ID: 24846344 [TBL] [Abstract][Full Text] [Related]
17. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer. Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Lago-Hernandez C; Choueiri TK; Elfiky AA; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Lathan CS; Trinh QD; Nguyen PL J Geriatr Oncol; 2014 Oct; 5(4):352-8. PubMed ID: 24862107 [TBL] [Abstract][Full Text] [Related]
18. Income inequality and treatment of African American men with high-risk prostate cancer. Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287 [TBL] [Abstract][Full Text] [Related]
19. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008. Cook MB; Rosenberg PS; McCarty FA; Wu M; King J; Eheman C; Anderson WF Prostate; 2015 May; 75(7):758-63. PubMed ID: 25619191 [TBL] [Abstract][Full Text] [Related]
20. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality. Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]